Celyad SA ADR Stock
Your prediction
Celyad SA ADR Stock
Our community identified positive and negative aspects for Celyad SA ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Celyad SA ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Celyad SA ADR in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Celyad SA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Celyad SA ADR | - | - | - | - | - | - | - |
| Cardio3 Biosciences S.A. | 0.000% | -1.141% | 0.000% | -66.667% | -3.704% | -89.499% | -98.074% |
| Intellia Therapeutics Inc | 0.810% | -9.382% | 32.961% | 13.077% | 34.256% | -73.826% | -81.510% |
| Chromadex Corp | -2.140% | -6.000% | -11.321% | -10.476% | -14.545% | 150.400% | 14.634% |